Home/Filings/4/0001209191-23-053982
4//SEC Filing

Lechleider Robert 4

Accession 0001209191-23-053982

CIK 0001472012other

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 6:30 PM ET

Size

8.8 KB

Accession

0001209191-23-053982

Insider Transaction Report

Form 4
Period: 2023-10-27
Lechleider Robert
Chief Medical Officer
Transactions
  • Award

    Stock option (right to buy)

    2023-10-27+400,000400,000 total
    Exercise: $8.73Exp: 2033-10-26Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on October 16, 2024, and the remaining shares will vest monthly thereafter over three years.

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1
  • filerCIK 0001997584

Filing Metadata

Form type
4
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 6:30 PM ET
Size
8.8 KB